|
XENE
|
Xenon Pharmaceuticals Inc.
|
0.17%
|
US
|
NASDAQ
|
|
RLAY
|
Relay Therapeutics, Inc.
|
0.17%
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
0.17%
|
US
|
NASDAQ
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
0.17%
|
US
|
NASDAQ
|
|
SAGE
|
Sage Therapeutics, Inc.
|
0.16%
|
US
|
NASDAQ
|
|
RVMD
|
Revolution Medicines, Inc.
|
0.16%
|
US
|
NASDAQ
|
|
VCYT
|
Veracyte, Inc.
|
0.15%
|
US
|
NASDAQ
|
|
KRYS
|
Krystal Biotech, Inc.
|
0.15%
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
0.15%
|
US
|
NASDAQ
|
|
AMPH
|
Amphastar Pharmaceuticals, Inc.
|
0.15%
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.15%
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
0.14%
|
US
|
NASDAQ
|
|
SUPN
|
Supernus Pharmaceuticals, Inc.
|
0.14%
|
US
|
NASDAQ
|
|
RXDX
|
Prometheus Biosciences, Inc.
|
0.14%
|
US
|
NASDAQ
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
0.14%
|
US
|
NASDAQ
|
|
CCXI
|
ChemoCentryx, Inc.
|
0.14%
|
US
|
NASDAQ
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
0.13%
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
0.13%
|
US
|
NASDAQ
|
|
TVTX
|
Travere Therapeutics, Inc.
|
0.12%
|
US
|
NASDAQ
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
0.12%
|
US
|
NASDAQ
|